New scanner aims to sharpen cancer radiation targeting

NCT ID NCT06576908

Completed Knowledge-focused Sponsor: Varian, a Siemens Healthineers Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new on-couch imaging system called HyperSight, which takes 3D X-ray pictures (CBCT) of cancer patients right before their radiation treatment. 46 adults with head/neck, chest, abdomen, or pelvic cancers received both the new HyperSight scan and a standard scan on their first, second, and last days of radiation. The goal was to compare image quality and see if the new system could provide clearer pictures to help doctors aim radiation more accurately.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HyperSight imaging device
What this could lead to: If successful, this imaging technology could help doctors see tumors more clearly during radiation treatment, potentially leading to more precise targeting and fewer side effects.
What could go wrong: This is a small, completed imaging study that only assessed image quality, not treatment outcomes. Better images may not always translate into better patient results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer digestive system cancer head and neck cancer Head and Neck Neoplasms Pelvic Neoplasms thoracic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL CANCER HEAD AND NECK CANCER PELVIC CANCER THORACIC CANCER

Contacts and locations

Locations

Princess Margaret Cancer Centre (University Health Network)

Toronto, Ontario, M5G 2M9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.